Randomized Controlled Trials as Topic
"Randomized Controlled Trials as Topic" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Works about clinical trials that involve at least one test treatment and one control treatment, concurrent enrollment and follow-up of the test- and control-treated groups, and in which the treatments to be administered are selected by a random process, such as the use of a random-numbers table.
Descriptor ID |
D016032
|
MeSH Number(s) |
E05.318.760.250.500.365.500 N05.715.360.775.088.500.387.500 N06.850.520.450.250.250.365.500
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Randomized Controlled Trials as Topic".
Below are MeSH descriptors whose meaning is more specific than "Randomized Controlled Trials as Topic".
This graph shows the total number of publications written about "Randomized Controlled Trials as Topic" by people in this website by year, and whether "Randomized Controlled Trials as Topic" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1993 | 0 | 1 | 1 |
1994 | 0 | 2 | 2 |
1995 | 0 | 1 | 1 |
1996 | 0 | 1 | 1 |
1997 | 0 | 3 | 3 |
1998 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
2000 | 0 | 1 | 1 |
2001 | 0 | 4 | 4 |
2002 | 1 | 1 | 2 |
2003 | 0 | 4 | 4 |
2004 | 0 | 7 | 7 |
2005 | 1 | 2 | 3 |
2006 | 0 | 5 | 5 |
2007 | 0 | 4 | 4 |
2008 | 0 | 8 | 8 |
2009 | 0 | 10 | 10 |
2010 | 0 | 5 | 5 |
2011 | 0 | 11 | 11 |
2012 | 2 | 10 | 12 |
2013 | 1 | 8 | 9 |
2014 | 0 | 12 | 12 |
2015 | 1 | 9 | 10 |
2016 | 2 | 18 | 20 |
2017 | 2 | 20 | 22 |
2018 | 4 | 15 | 19 |
2019 | 6 | 19 | 25 |
2020 | 4 | 17 | 21 |
2021 | 1 | 22 | 23 |
2022 | 0 | 10 | 10 |
To return to the timeline,
click here.
Below are the most recent publications written about "Randomized Controlled Trials as Topic" by people in Profiles.
-
Study protocol for a hybrid type 1 effectiveness-implementation trial testing virtual tobacco treatment in oncology practices [Smokefree Support Study 2.0]. BMC Public Health. 2022 07 15; 22(1):1359.
-
What proportion of patients with stage 3 ovarian cancer are potentially cured following intraperitoneal chemotherapy? Analysis of the long term (=10 years) survivors in NRG/GOG randomized clinical trials of intraperitoneal and intravenous chemotherapy in stage III ovarian cancer. Gynecol Oncol. 2022 09; 166(3):410-416.
-
An audit of safety reporting in randomized controlled trials over a five-year period in a high impact factor journal. J Postgrad Med. 2022 Jul-Sep; 68(3):133-137.
-
Management of acute chest syndrome in patients with sickle cell disease: a systematic review of randomized clinical trials. Expert Rev Hematol. 2022 06; 15(6):547-558.
-
Incomplete reporting of patient-reported outcomes in multiple sclerosis: A meta-epidemiological study of randomized controlled trials. Mult Scler Relat Disord. 2022 Jul; 63:103819.
-
Supportive oncology care at home interventions: protocols for clinical trials to shift the paradigm of care for patients with cancer. BMC Cancer. 2022 Apr 09; 22(1):383.
-
Impact of autologous transplantation on survival in patients with newly diagnosed multiple myeloma who have high-risk cytogenetics: A meta-analysis of randomized controlled trials. Cancer. 2022 06 15; 128(12):2288-2297.
-
Comparison of an automated smartphone-based smoking cessation intervention versus standard quitline-delivered treatment among underserved smokers: protocol for a randomized controlled trial. BMC Public Health. 2022 03 22; 22(1):563.
-
Evaluation of Proposed Protocol Changing Statistical Significance From 0.05 to 0.005 in Foot and Ankle Randomized Controlled Trials. J Foot Ankle Surg. 2022 Sep-Oct; 61(5):925-926.
-
Study protocol for a cluster randomized trial of a school, family, and community intervention for preventing drug misuse among older adolescents in the Cherokee Nation. Trials. 2022 Feb 23; 23(1):175.